UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000019425
Receipt No. R000022466
Scientific Title Clinical Study of the Acceptability of Sanitary Napkin
Date of disclosure of the study information 2015/12/01
Last modified on 2019/05/09 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Clinical Study of the Acceptability of Sanitary Napkin
Acronym Clinical Study of the Acceptability of Sanitary Napkin
Scientific Title Clinical Study of the Acceptability of Sanitary Napkin
Scientific Title:Acronym Clinical Study of the Acceptability of Sanitary Napkin
Region
Asia(except Japan)

Condition
Condition Healthy adult females
Classification by specialty
Dermatology Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The objective of this study is to evaluate the acceptability of new sanitary napkin in subjects who experienced napkin dermatitis.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes This is an open, prospective study in order to evaluate the skin condition on genital area during the using of sanitary napkin and to evaluate skin's properties measurement (Skin hydration and skin pH)
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Other
Interventions/Control_1 Usage test of new sanitary napkin in subjects who experienced napkin dermatitis after the using of their usual sanitary napkin during their last menstrual cycle.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
50 years-old >
Gender Female
Key inclusion criteria -Healthy females
-Individuals who has experience of any symptoms of the itchiness or the offensive senses under the usage of feminine hygiene products during the last 3 menstrual period before screening.
Key exclusion criteria -Use of systemic medications or any medicated anti-pruritic or anti-fungal topical products to the genital area within 2 weeks of baseline measurements.
-Individuals with the symptom that is apparently necessary of doctor's care.
-Pregnancy, nursing, or planning to become pregnant during the study as determined by the health questionnaire.
Target sample size 40

Research contact person
Last name of lead principal investigator
1st name
Middle name
Last name Dr. Danang Agung Yunaidi
Organization PT Equilab International
Division name Clinical research
Zip code
Address JI. RS. Fatmawati Persil 33 Jakarta 12430 Indonesia
TEL +62-21-7695513
Email danang@equilab-int.com

Public contact
1st name of contact person
1st name
Middle name
Last name Effi Setiawati, Pharm.
Organization PT Equilab International
Division name Office
Zip code
Address JI. RS. Fatmawati Persil 33 Jakarta 12430 Indonesia
TEL +62-21-7695513
Homepage URL
Email effi@equilab-int.com

Sponsor
Institute PT Equilab International
Institute
Department

Funding Source
Organization Kao Corporation
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions PT Equilab International

Other administrative information
Date of disclosure of the study information
2015 Year 12 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 11 Month 30 Day
Date of IRB
2015 Year 11 Month 30 Day
Anticipated trial start date
2015 Year 12 Month 02 Day
Last follow-up date
2016 Year 12 Month 30 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2015 Year 10 Month 20 Day
Last modified on
2019 Year 05 Month 09 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022466